Viewing Study NCT04086758


Ignite Creation Date: 2025-12-25 @ 12:11 AM
Ignite Modification Date: 2026-01-04 @ 6:56 PM
Study NCT ID: NCT04086758
Status: COMPLETED
Last Update Posted: 2024-11-20
First Post: 2019-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Sponsor: Astellas Pharma China, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module